While the County of Los Angeles in Southern California deliberates over take-back legislation, the number of Counties in Northern California to pass take-back ordinances continues to grow.
CLSA continues to advocate for solutions to the Silicon Valley-Bay Area transportation gridlock as part of the C3 coalition so our member company employees can more easily commute.
In 2017, CLSA will continue to direct and expand its one-of-a-kind locally-focused program throughout the state. California has 58 Counties, and 482 municipalities, each with its own governmental role and procedures. CLSA actively monitors and responds to legislation in each of these jurisdictions as appropriate for our members.
The entire San Francisco Bay Area will have county-by-county based drug takeback ordinances by early 2017.
Elections in the Bay Area’s Counties and Cities have their mark on the local landscape.
CLSA is pleased to provide you with this exclusive 2016 local election update, and what these results mean for California’s life sciences sector.
This November, the citizens of the County of Sonoma will vote on a measure to ban genetically modified organisms (GMO’s) in the County.
The City and County of San Francisco continue to delve into a number of issues important to the Bay Area’s life sciences sector.
CLSA’s sponsored bill, Assembly Bill 2115, passed out of Senate Health Committee unanimously on June 29, and now moves on to Senate Appropriations for a hearing in early August.
On June 14, the Los Angeles County Board of Supervisors voted 3-0 (2 abstained) to sidestep its original drug/sharps takeback ordinance and instead support a public education and outreach campaign with quarterly takeback events, as endorsed by CLSA and a host of national industry association partners.